Literature DB >> 21182764

Concurrent breast stroma sarcoma and breast carcinoma: a case report.

Ramon Andrade de Mello1, Paulo Figueiredo, Mariela Marques, Gabriela Sousa, Teresa Carvalho, Helena Gervásio.   

Abstract

INTRODUCTION: Breast cancer is one of the most important health problems in the world and affects a great number of women over the entire globe. This group of tumors rarely presents as bilateral disease and, when it does happen, normally occurs within the same histological type. We report a rare case of concurrent bilateral breast cancer with two different histology types, a breast carcinoma and a breast sarcoma, in a 42-year-old woman referred to our hospital. CASE
PRESENTATION: A 42-year-old Caucasian woman admitted to our institute in August 1999, presented with a nodule in the left breast of 3.0 × 2.5 cm, and, in the right breast, one of 1.0 cm, suspected of malignancy and with a clinically negative armpit. Biopsies had revealed invasive mammary carcinoma (right breast) and sarcoma (left breast). She was submitted to bilateral modified radical mastectomy. A histological study showed an invasive mammary carcinoma degree II lobular pleomorphic type with invasion of seven of the 19 excised axillary nodes in the right breast and, in the left breast, a sarcoma of the mammary stroma, for which the immunohistochemistry study was negative for epithelial biomarkers and positive for vimentin. Later, she was submitted for chemotherapy (six cycles of 75 mg/m2 5-fluorouracil, epirubicin and cyclophosphamide) followed by radiotherapy of the thoracic wall and axillary nodes on the left. Hormone receptors were positive in the tumor of the right breast, and tamoxifen, 20 mg, was prescribed on a daily basis (five years) followed by letrozole, 2.5 mg, also daily (five years). She presented no sign of negative evolution in the last consultation.
CONCLUSION: The risk of development of bilateral breast cancer is about 1% each year within a similar histological type, but it is higher in tumors with lobular histology. In this case, the patient presented, simultaneously, two histologically distinct tumors, thus evidencing a rare situation.

Entities:  

Year:  2010        PMID: 21182764      PMCID: PMC3022674          DOI: 10.1186/1752-1947-4-414

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  16 in total

1.  Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.

Authors:  Paul J Chuba; Merlin R Hamre; Johnny Yap; Richard K Severson; David Lucas; Falah Shamsa; Amr Aref
Journal:  J Clin Oncol       Date:  2005-08-20       Impact factor: 44.544

Review 2.  Epidemiology of contralateral breast cancer.

Authors:  Y Chen; W Thompson; R Semenciw; Y Mao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-10       Impact factor: 4.254

3.  Stromal sarcoma of the breast: a case report.

Authors:  Ashraf F Hefny; Masoud O Bashir; Sandhya Joshi; Frank J Branicki; Fikri M Abu-Zidan
Journal:  Asian J Surg       Date:  2004-10       Impact factor: 2.767

4.  Bilateral breast cancer.

Authors:  J Skowronek; T Piotrowski
Journal:  Neoplasma       Date:  2002       Impact factor: 2.575

5.  Bilateral breast carcinoma treated with definitive irradiation.

Authors:  L J Solin; B L Fowble; D J Schultz; R L Goodman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-08       Impact factor: 7.038

6.  MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results.

Authors:  Steven G Lee; Susan G Orel; Irene J Woo; Eva Cruz-Jove; Mary E Putt; Lawrence J Solin; Brian J Czerniecki; Mitchell D Schnall
Journal:  Radiology       Date:  2003-01-31       Impact factor: 11.105

7.  Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

Authors:  Kelly Metcalfe; Henry T Lynch; Parviz Ghadirian; Nadine Tung; Ivo Olivotto; Ellen Warner; Olufunmilayo I Olopade; Andrea Eisen; Barbara Weber; Jane McLennan; Ping Sun; William D Foulkes; Steven A Narod
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

8.  Pre-operative diagnosis of breast cancer in screening: problems and pitfalls.

Authors:  Elena Provenzano; Sarah E Pinder
Journal:  Pathology       Date:  2009-01       Impact factor: 5.306

Review 9.  [New trends in diagnostics and classification of breast carcinoma].

Authors:  A Ryska; J Laco; H Hornychová; E Hornychová; B Melichar
Journal:  Cesk Patol       Date:  2009-04

Review 10.  Personalized therapy of sarcomas: integration of biomarkers for improved diagnosis, prognosis, and therapy selection.

Authors:  Joseph A Ludwig
Journal:  Curr Oncol Rep       Date:  2008-07       Impact factor: 5.075

View more
  2 in total

1.  Metastatic melanoma and vemurafenib: novel approaches.

Authors:  Ramon Andrade De Mello
Journal:  Rare Tumors       Date:  2012-05-17

2.  Primary Stromal Breast Sarcoma with Concomitant Contralateral Carcinoma: A Rare Case from Syria.

Authors:  Rawan Al Khudari; Mohannad Homsi; Hasan Al Zohaily; Maher S Saifo
Journal:  Case Rep Oncol Med       Date:  2019-09-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.